Preventing Morbidity in First Episode Schizophrenia, Part II.
Phase of Trial: Phase IV
Latest Information Update: 15 Sep 2016
At a glance
- Drugs Aripiprazole (Primary) ; Risperidone (Primary)
- Indications Psychotic disorders; Schizoaffective disorder; Schizophrenia
- Focus Therapeutic Use
- 07 Jan 2016 Status changed from active, no longer recruiting to completed as per ClinicalTrials.gov record.
- 13 May 2015 Planned End Date changed from 1 Oct 2015 to 1 Dec 2015 as per ClinicalTrials.gov record.
- 29 May 2013 Planned end date changed from 1 Oct 2013 to 1 Oct 2015 as reported by ClinicalTrials.gov.